J&J’s DePuy Synthes Gets A Go-Ahead For Its 3D-Printed Titanium
Johnson & Johnson subsidiary DePuy Synthes, along with Belgian 3D printing leader, Materialise, has announced that its patient-specific implants, 3D printed in titanium for maxillofacial surgery, have been approved for use in the U.S.
The new products will be distributed through an exclusive agreement with Materialise. With the addition of personalized Titanium 3D-Printed Implants, DePuy Synthes is now able to offer TRUMATCH Orthognathics, a personalized total solution for orthognathic surgery, also known as corrective jaw surgery, as well as Titanium 3D-Printed Implants for other facial reconstruction applications.
Having already reported positive results in European and Australian markets since its introduction in 2016, the system will help deliver better aesthetics and minimise surgery time for patients in the U.S. through virtual surgical planning to the 3D printed implants used in combination with 3D printed surgical guides.
“We have been using Trumatch Orthognathics for more than a year and the use of these personalized surgical guides and plates demonstrate a high predictability of maxillary positioning. In addition to saving time in the OR, the use of this new digital approach may achieve surgeon independent accuracy of maxillary positioning, facilitating resident training even in the treatment of complex
malformations,” Dr. Alexander Schramm of Germany’s University Hospital and Military Hospital Ulm said in a press release.“As the first of our extensive selection of implants to receive clearance for the U.S. markets, the decision is a real milestone for our medical department,” said Brigitte de Vet, Vice President of Materialise Medical. “Thanks to our partnership with DePuy Synthes, our devices will be able to provide better healthcare for as many patients as possible.”
“For seven years now I’ve experienced the benefits of 3D printed implants firsthand – they simplify maxillofacial surgery and allow me to perform procedures more accurately, saving time in the OR and improving patient outcomes,” Dr. Thomas Schouman, CMF surgeon at Groupe Hospitalier Pitié Salpêtrière, France, commented. “Moreover, they offer new treatment possibilities, allowing me to perform more complex surgeries or multiple procedures in a single intervention whereas without the implants several interventions would be necessary.”
